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The increasing attention being paid by researchers
to studies in the field of stereoselective synthesis and
catalysis, as well as methods of chromatographic sepa-
ration of chiral phases, observed over the last decade, is
due to the requirements of the World Health Organiza-
tion for the optical purity of drugs. The lack of univer-
sally applicable chiral phases for separating optical iso-
mers prompts researchers to develop new sorbents.
Immobilized macrocyclic glycopeptide antibiotics
(including vancomycin, teichoplanin, ristocetin A,
avoparcin, etc.) proved to serve as chiral phases for reli-
able HPLC separation of a wide range of drugs [1–4].
The high enantioselectivity of the sorbents belonging to
this class is due to the presence of structurally diverse
fragments capable of multiple-point interactions with
the compounds to be separated (in both polar and non-
polar solvents). Immobilization of new antibiotics [5],
chemical modifications of their structure [6], and
refinement of immobilization techniques [7] offer addi-
tional possibilities for changing the enantioselectivity
of sorbents belonging to this class.
It was previously shown that eremomycin (a new
antibiotic manufactured in Russia), in contrast to its
closest structural analogue vancomycin, exhibits high
enantioselectivity in separating isomers of 
 
α
 
 amino
acids when immobilized on silica gel [8]. A method of
its immobilization was developed that increased the
selectivity of the separation, thus, rendering the sorbent
superior to other chiral selectors in separating isomers
of 
 
α
 
 amino acids [9].
In this work, we sought to explore the capacity of
the new eremomycin sorbent for separating enanti-
omers of other classes (profens) and study the effects of
structural modification of eremomycin on its enantiose-
lectivity, as compared to the known chiral selectors
vancomycin and ristomycin.
MATERIALS AND METHODS
 
Reagents. 
 
The antibiotics were immobilized using
modified silica gels: Diaspher-110-Epoxy (particle
size, 6 
 
µ
 
m; specific surface, 313 m
 
2
 
/g; pore diameter,
11 nm; carbon content, 5.2%) and Diasorb-130-Epoxy
(particle size, 6 
 
µ
 
m; specific surface, 280 m
 
2
 
/g; pore
diameter, 13 nm; carbon content, 4.8%) manufactured
by BioChemMack ST Russia. The eluants were pre-
pared using methanol, acetic acid, and triethylamine
(Fluka, Switzerland). Eremomycin and ristomycin
were synthesized using a pilot plant at the Hause Insti-
tute for New Antibiotics (Russia) [10, 11]. Vancomycin
was provided by the joint stock company Veropharm
(Russia). The profens and amino acids were purchased
from Sigma (United States).
 
Obtaining eremosaminyl aglycon of eremomycin
[4].
 
 Eremomycin (3 g) was dissolved in 30 ml of dime-
thyl sulphoxide, and the solution was supplemented
with 2 ml of 80% sulfuric acid, after which the mixture
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was heated for 3 h. The target product was separated
chromatographically in a 
 
2.5 
 
×
 
 11.5
 
 cm column packed
with Diasorb-130-C16T (particle size, 63–200 
 
µ
 
m;
BioChemMack ST); aqueous acetonitrile supple-
mented with 0.1% trifluoroacetate served as the mobile
phase (0–25% acetonitrile gradient). The excess sol-
vents were removed using rotary evaporation. The yield
of the product was 50%; its purity by HPLC was 87%.
 
Obtaining silica gel-immobilized eremomycin
(E-SiO
 
2
 
).
 
 Eremomycin (2 g) was dissolved in 50 ml of
distilled water, and the pH of the solution was adjusted
to 8.6 by dropwise addition of 1 M KOH. The solution
thus obtained was mixed with 10 g Diaspher-110-
Epoxy, and the suspension was heated at 
 
40°ë
 
 for 14 h
under stirring. Following the completion of the reac-
tion, the sorbent was separated by filtration, washed
(with water, methanol, and acetone, in sequence), and
dried at 
 
50°ë
 
 for 4 h. The data of the elemental analysis
(12.6% C, 2.29% H, 1.2% N) corresponded to an
engraftment density of 0.35
 
µ
 
mol/m
 
2
 
.
 
Obtaining silica gel-immobilized eremosaminyl
aglycon of eremomycin (EA-SiO
 
2
 
), ristomycin
(R-SiO
 
2
 
), and vancomycin (V-SiO
 
2
 
)
 
. An aliquot (1 g)
of a glycopeptide antibiotic was dissolved in a mixture
of 15 ml distilled water and 5 ml ethanol. Thereafter,
the synthesis was performed as described above for
E-
 
SiO
 
2
 
, except that the amount of Diaspher-110-Epoxy
equaled 5 g and Diasorb-130-Epoxy was used for the
vancomycin immobilization. The engraftment densi-
ties calculated from the data of the elemental analyses
(EA-
 
SiO
 
2
 
: 9.1% C, 2.1% H, 1.1% N; R-SiO
 
2
 
: 13.1% C,
1.9% H, 1.6% N; V-SiO
 
2
 
: 8.3% C, 1.6% H, 1.8% N)
correspond to 0.21, 0.3, and 0.2 
 
µ
 
mol/m
 
2
 
.
Stainless steel 
 
4 
 
× 
 
250
 
 mm columns were packed
with the sorbents using a suspension technique (at
60 MPa). The chromatograph used in the work
(Knauer, Germany) consisted of a K-1001 pump, a
K-2501 spectrophotometric detector, and a dosing
valve with a 20-
 
µ
 
l sample loop. The volume of the sam-
ple was in the range 5–20 
 
µ
 
l. The chromatograms were
recorded and the results were processed, including the
calculation of the retention (
 
Í
 
), selectivity (
 
a
 
), and res-
olution (
 
R
 
s
 
) factors, using Multikhrom software
(Ampersand, Russia). The idle time was determined by
loading the column with a toluene solution in methanol
and eluting it with methanol (photometric detection
was performed at 210 nm).
RESULTS AND DISCUSSION
Figure 1 presents the chemical structures of the
immobilized chiral selectors, which show that each
selector contains 18–38 chiral centers. It is also clear
from the figure that the selectors differ in the number
and type of functional groups capable of participating
in chiral recognition of isomers. This variability makes
it difficult to understand the mechanism whereby enan-
tiomers are separated by macrocyclic glycopeptide
antibiotics, in spite of the abundant reports on the sub-
ject. For example, sorbents containing teichoplanin, its
aglycon, or ristomycin A (ristocetin) are highly selec-
tive in separating the isomers of 
 
α
 
 amino acids,
whereas immobilized vancomycin fails to exhibit
appreciable enantioselectivity [1].
We were able to previously demonstrate that a sor-
bent engrafted with eremomycin (the closest structural
analog of vancomycin) exhibited unexpectedly high
selectivity in separating enantiomers of 
 
α 
 
amino acids
[8, 9]. It is conceivable that the selectivity of eremomy-
cin is due to its differences from vancomycin, such as
the absence of a chlorine atom in the aromatic fragment
and the presence of an additional aminoglucoside in the
carbohydrate portion of the molecule [10]. Moreover,
the carbohydrate residue of eremosamine is stere-
ochemically different from that of vancosamine in the
configuration of the C4 atom [11].
Studies of sorbents containing surface-fixed eremo-
mycin analogues are of interest for obtaining an insight
into the mechanism of chiral recognition of 
 
α
 
 amino
acids by the eremomycin-engrafted sorbent. In this
work, we obtained eremosaminyl aglycon of eremomy-
cin (by eremomycin hydrolysis) and synthesized a
chiral sorbent containing this compound (EA-
 
SiO
 
2
 
). As
shown in Table 1, the absence of eremosamine in the
chiral selector increases its enantioselectivity for 
 
α
 
amino acids with aliphatic side chains; however, the
separation of isomers of aromatic amino acids is negli-
gible. Eremosamine likely plays and important part in
the chiral recognition of enantiomers of aromatic
amino acids, possibly by virtue of creating ancillary
steric effects.
The new chiral phases E-
 
SiO
 
2
 
 and EA-
 
SiO
 
2
 
 are not
limited to separating solely optical isomers of 
 
α
 
 amino
acids. Table 1 contains an example of separation of
enantiomers of an 
 
α
 
 hydroxyacid (lactic acid), whereas
Table 2 and Figs. 2 and 3 show the results of separation
of isomers of profens (
 
α
 
 methyl-substituted acids).
Data from the literature indicate that chiral phases
with engrafted macrocyclic antibiotics show promise in
the separation of profens, which exhibit anti-inflamma-
tory effects [12–15]. The therapeutic activity, how-
ever, resides in only one profen enantiomer, hence, the
need for separation and determination of profens.
Separation of racemic profens was studied using two
types of eluants: (1) aqueous methanol (reversed-
phase HPLC; RP-HPLC) and (2) 100% methanol sup-
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Fig. 1.
 
 Structural formulae of immobilized chiral selectors.
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plemented with triethylamine and acetic acid (polar
ionic HPLC; PI-HPLC) [2].
Analysis of the results obtained indicates that opti-
mum separation of profens is achieved by using eremo-
mycin-engrafted silica gel. The selectivity and high res-
olution were achieved in both variants (RP-HPLC and
PI-HPLC). For all the profens except phenoprofen, the
values of 
 
R
 
s
 
 achieved under optimum conditions
exceeded 1.5, which ensured isomer separation down to
the baseline. For phenoprofen, the maximum 
 
R
 
s
 
 value
equaled 1.42. As a rule, the RP-HPLC setting showed
higher values of selectivity and resolution for all the
sorbents; however, the peaks were wider than in the
PI-HPLC setting (Table 2 and Fig. 3).
 
Reversed-phase setting.
 
 The retention of profens
did not correspond to their lipophilicity, which indi-
cated that, in aqueous methanol, the effects of addi-
tional, specific interactions with macrocyclic glycopep-
tide antibiotics were considerable. A decrease in the
retention of both enantiomers, observed on increasing
pH of the eluant, was the general pattern characteristic
of RP-HPLC for all the sorbents studied. In the case of
 
R-SiO
 
2
 
 and E-
 
SiO
 
2
 
, this effect was paralleled by a
decrease in the peak resolution (
 
R
 
s
 
), although the selec-
tivity remained virtually unchanged (Fig. 2). With
EA-SiO
 
2
 
, both 
 
R
 
s
 
 and 
 
α
 
 (the enantioselectivity)
increased with the pH of the eluant, even though not
considerably. Of interest, this sorbent failed to separate
enantiomers of indoprofen, which is likely due to the
predominantly nonchiral binding of this compound to
the graft, at least in aqueous methanol. On the whole,
the best results of RP-HPLC separation of indoprofen
and ibuprofen were achieved with E-
 
SiO
 
2
 
 (the maxi-
mum values of 
 
α
 
 equaled 1.99 and 1.70), and those of
ketoprofen and phenoprofen, respectively, with 
 
R-SiO
 
2
 
(
 
α
 
 1.94)
 
 and EA-
 
SiO
 
2
 
 (
 
α
 
 1.58)
 
. Thus, the operational
characteristics of our sorbents are superior to those of
commercially available phases (such as Chirobiotic)
[12–15].
 
Table 1.  
 
Values of the enantioselectivity (
 
α
 
) and resolution (
 
R
 
s
 
) of columns packed with immobilized eremomycin or its ag-
lycon in separating enantiomers of 
 
α
 
 amino acids (eluant, methanol–water 50 : 50)
 
α
 
 Amino acid
E-SiO
 
2
 
EA-SiO
 
2
 
α
 
R
 
s
 
α
 
R
 
s
 
Alanine 2.37 2.94 2.78 2.95
Valine 3.35 4.09 5.89 4.58
Leucine 2.54 3.64 3.48 5.20
Norvaline 2.65 3.76 4.50 6.34
Methionine 2.23 4.19 3.23 5.20
Proline 7.94 7.75 5.63 4.40
Phenylalanine 3.98 6.05 1 0
Tyrosine 5.05 9.91 1 0
3,4-dihydroxyphenylalanine 4.28 10.03 1.16 0.62
Lactic acid* 2.11 5.76 2.69 4.31
 
* Eluant, CH
 
3
 
OH – 0.1 M NaH
 
2
 
PO
 
4
 
 (1 : 4)
 
.
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Table 2.  
 
Values of the retention (
 
κ
 
), enantioselectivity (
 
α
 
), and resolution (Rs) factors characterizing profen separation under
the conditions of polar ionic (eluants 1–3) and reversed-phase (eluant 4) HPLC
Compound Sorbent Eluant* k1 α Rs
Phenoprofen
E-SiO2 1 1.48 1.12 0.93
2 2.02 1.11 1.01
3 1.99 1.11 0.89
4 4.18 1.32 1.42
EA-SiO2 1 0.81 1.17 1.19
2 1.04 1.18 1.39
3 0.99 1.17 1.14
4 3.28 1.58 1.59
R-SiO2 1 0.71 1.08 0.76
2 0.93 1.09 0.91
3 0.89 1.09 0.91
4 0.68 1.29 1.93
V-SiO2 1 0.46 1 0
2 0.60 1 0
3 0.61 1 0
Ibuprofen
E-SiO2 1 0.83 1.28 1.71
2 1.04 1.27 1.85
3 1.27 1.25 1.73
4 3.06 1.70 2.18
EA-SiO2 1 0.54 1.15 0.77
2 0.65 1.15 0.91
3 0.78 1.14 0.80
4 2.83 1.67 1.50
R-SiO2 1 0.37 1 0
2 0.48 1 0
3 0.55 1 0
4 5.16 1.15 1.48
V-SiO2 1 0.26 1 0
2 0.31 1 0
3 0.41 1 0
Indoprofen
E-SiO2 1 2.82 1.28 2.03
2 3.68 1.29 2.14
3 3.87 1.27 1.98
4 2.15 1.99 2.08
EA-SiO2 1 2.29 1.17 1.03
2 2.80 1.17 1.07
3 2.91 1.18 0.86
4 5.95 1 0
R-SiO2 1 1.55 1.07 0.58
2 1.93 1.07 0.72
3 1.95 1.08 0.87
4 1.37 1.27 2.11
V-SiO2 1 0.89 1.06 0.43
2 1.10 1.06 0.52
3 1.17 1.10 0.60
O
COOH
CH3
H3C
COOH
CH3
CH3
N
O
CH3
COOH
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Table 2.  (Contd.)
Compound Sorbent Eluant* k1 α Rs
Ketoprofen
E-SiO2 1 2.20 1.17 1.50
2 3.17 1.17 1.59
3 2.71 1.15 1.28
4 3.79 1.55 2.47
EA-SiO2 1 1.30 1.08 0.54
2 1.75 1.09 0.67
3 1.45 1.09 0.54
4 2.99 1.24 0.79
R-SiO2 1 1.05 1.19 1.95
2 1.48 1.19 2.23
3 1.18 1.20 2.13
4 0.88 1.94 5.35
V-SiO2 1 0.65 1.08 0.61
2 0.88 1.09 0.91
3 0.78 1.09 0.89
Flurbiprofen
E-SiO2 1 1.59 1.48 3.27
2 2.31 1.46 3.51
3 1.99 1.45 3.00
EA-SiO2 1 1.26 1.08 0.51
2 1.66 1.08 0.56
3 1.43 1.06 0.39
R-SiO2 1 0.80 1.04 0.34
2 1.13 1.04 0.46
3 0.90 1.07 0.55
V-SiO2 1 0.49 1.14 1.15
2 0.68 1.16 1.44
3 0.59 1.20 1.42
* 100% CH3OH with supplements: (1) 0.2% (C2H5)3N and 0.2% CH3COOH; (2) 0.1% (C2H5)3N and 0.2% CH3COOH; and (3) 0.2%(C2H5)3N and 0.1% CH3COOH. (4), 40% CH3OH : 60% 0.1 M phosphate buffer.
COOH
CH3O
F
C
CH3
COOH
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The sorbent with immobilized vancomycin exhib-
ited no selectivity for profens in the RP-HPLC setting;
its appreciable selectivity under the conditions of PI-
HPLC was limited to flurbiprofen, however.
Polar-ionic setting. The use of 100% methanol sup-
plemented with acetic acid and organic bases (e.g., tri-
ethylamine) as an eluant makes it possible to suppress
the undesirable ion-exchange interactions between the
sorbate and the chiral phase (noted when indoprofen
enantiomers were separated on EA-SiO2 under the con-
ditions of RP-HPLC). As a result, the shape of the chro-
matographic peaks is improved, even though the selec-
tivity and resolution become less pronounced (Table 2).
The separation of indoprofen isomers on EA-SiO2 is an
exceptional case, since the value of α increased from
1.0 to 1.17.
As in the case of the RP-HPLC setting, satisfactory
separation of profen enantiomers under the conditions
of PI-HPLC was achieved with one sorbent, E-SiO2.
Other sorbents could be used for separating one or two
sorbates, thus, showing a certain degree of specificity.
For example, the use of R-SiO2 ensured the optimum
separation of racemic ketoprofen, whereas EA-SiO2
and V-SiO2 ensured the optimum separation of racemic
phenoprofen and flurbiprofen, respectively.
In conclusion, a silica gel carrying eremomycin (a
surface-fixed macrocyclic glycopeptide antibiotic)
exhibits high enantioselectivity in separating isomers
of α amino and hydroxy acids, as well as enantiomers
of various derivatives of 2-arylpropanoic acid (the so-
called profens). The operational parameters of this sor-
bent are not inferior to those of commercially available
analogs. With immobilized ristomycin A as an exem-
plary case, it is shown that the proposed method of
engraftment increases the enantioselectivity of the sil-
ica gel-fixed selector for isomers of α methyl as well as
α amino acids (profens).
The values of selectivity achieved under the condi-
tions of reversed-phase chromatography suggest that
the sorbents can be used for both analytical and prepar-
ative separation of profen enantiomers.
Rs
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Fig. 2. pH-dependence of the resolution (Rs) of chromatographic peaks of enantiomers of indoprofen (a), ibuprofen (b), phenopro-
fen (c), and ketoprofen (d) on chiral phases with silica gel carrying engrafted macrocyclic antibiotics: eremomycin (1), eremosami-
nyl aglycon (2), and ristomycin (3). Eluant, 40% CH3OH and 60% 0.1 M phosphate buffer.
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